Assessing patients' improvement in clinical trials.
作者信息
Spertus John
出版信息
BMJ. 2008 Jun 7;336(7656):1258-9. doi: 10.1136/bmj.39570.393218.BE. Epub 2008 May 21.
Abstract
Should the doctor or patient judge improvement, and does it matter?
摘要
相似文献
1
Assessing patients' improvement in clinical trials.
BMJ. 2008 Jun 7;336(7656):1258-9. doi: 10.1136/bmj.39570.393218.BE. Epub 2008 May 21.
2
Doctors' versus patients' global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials.
BMJ. 2008 Jun 7;336(7656):1287-90. doi: 10.1136/bmj.39560.759572.BE. Epub 2008 May 21.
3
The covariance decomposition of the probability score and its use in evaluating prognostic estimates. SUPPORT Investigators.
Med Decis Making. 1995 Apr-Jun;15(2):120-31. doi: 10.1177/0272989X9501500204.
4
[Perceptions of patients and physicians involved in clinical trials: an overview of the literature].
Therapie. 2006 Sep-Oct;61(5):425-37. doi: 10.2515/therapie:2006072.
5
Patients' and physicians' experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design.
Psychol Health. 2016;31(4):436-55. doi: 10.1080/08870446.2015.1116534. Epub 2015 Dec 21.
6
In the eye of the beholder.
Arch Intern Med. 1995 Nov 27;155(21):2277-80.
7
Measuring (shared) decision-making--a review of psychometric instruments.
Z Arztl Fortbild Qualitatssich. 2007;101(4):259-67. doi: 10.1016/j.zgesun.2007.02.029.
8
Why patients receive treatments that are minimally effective?
Nat Rev Clin Oncol. 2019 Jan;16(1):3-4. doi: 10.1038/s41571-018-0101-4.
9
Interactional styles of nurse practitioners and physicians regarding patient decision making.
Nurs Res. 1989 Jan-Feb;38(1):50-5.
10
When doctor and patient disagree.
J Gen Intern Med. 1993 Oct;8(10):580-1. doi: 10.1007/BF02599645.
引用本文的文献
1
Quantifying clinical change: discrepancies between patients' and providers' perspectives.
Qual Life Res. 2016 Sep;25(9):2213-20. doi: 10.1007/s11136-016-1267-9. Epub 2016 Mar 19.
本文引用的文献
1
Doctors' versus patients' global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials.
BMJ. 2008 Jun 7;336(7656):1287-90. doi: 10.1136/bmj.39560.759572.BE. Epub 2008 May 21.
2
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.
Health Qual Life Outcomes. 2006 Oct 11;4:79. doi: 10.1186/1477-7525-4-79.
3
Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure.
Heart. 2007 Apr;93(4):476-82. doi: 10.1136/hrt.2006.089656. Epub 2006 Sep 27.
4
Monitoring clinical changes in patients with heart failure: a comparison of methods.
Am Heart J. 2005 Oct;150(4):707-15. doi: 10.1016/j.ahj.2004.12.010.
5
Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?
Am Heart J. 2001 Nov;142(5):745-7. doi: 10.1067/mhj.2001.119135.
6
Preferences for quality of life or survival expressed by patients with heart failure.
J Heart Lung Transplant. 2001 Sep;20(9):1016-24. doi: 10.1016/s1053-2498(01)00298-4.
7
Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.
Lancet. 1999 Sep 11;354(9182):885-90. doi: 10.1016/s0140-6736(99)08113-1.
8
Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project.
JAMA. 1998 Feb 4;279(5):371-5. doi: 10.1001/jama.279.5.371.
9
Measuring health-related quality of life.
Ann Intern Med. 1993 Apr 15;118(8):622-9. doi: 10.7326/0003-4819-118-8-199304150-00009.
10
Determining a minimal important change in a disease-specific Quality of Life Questionnaire.
J Clin Epidemiol. 1994 Jan;47(1):81-7. doi: 10.1016/0895-4356(94)90036-1.
Zotero 插件